Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 429

1.

The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review.

Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, Radue EW, McGuire PK, Riecher-Rössler A, Borgwardt SJ.

Curr Pharm Des. 2009;15(22):2535-49. Review.

PMID:
19689326
2.

Effects of antipsychotics on brain structure.

Scherk H, Falkai P.

Curr Opin Psychiatry. 2006 Mar;19(2):145-50. Review.

PMID:
16612194
3.

Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia.

Tomelleri L, Jogia J, Perlini C, Bellani M, Ferro A, Rambaldelli G, Tansella M, Frangou S, Brambilla P; Neuroimaging Network of the ECNP networks initiative.

Eur Neuropsychopharmacol. 2009 Dec;19(12):835-40. doi: 10.1016/j.euroneuro.2009.07.007. Epub 2009 Aug 29.

PMID:
19717283
4.

[Changes in brain structure caused by neuroleptic medication].

Scherk H, Falkai P.

Nervenarzt. 2004 Nov;75(11):1112-7. Review. German.

PMID:
15365632
5.

Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.

Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M.

Arch Gen Psychiatry. 2003 Jun;60(6):585-94.

PMID:
12796222
7.

Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment.

McClure RK, Carew K, Greeter S, Maushauer E, Steen G, Weinberger DR.

Schizophr Res. 2008 Jan;98(1-3):29-39. Epub 2007 Oct 31.

PMID:
17976957
8.

The effects of antipsychotic treatment on cerebral structure and function in schizophrenia.

Vita A, De Peri L.

Int Rev Psychiatry. 2007 Aug;19(4):429-36. Review.

PMID:
17671875
9.

The effects of antipsychotics on brain structure: what have we learnt from structural imaging of schizophrenia?

Borgwardt SJ, Smieskova R, Fusar-Poli P, Bendfeldt K, Riecher-Rössler A.

Psychol Med. 2009 Nov;39(11):1781-2. doi: 10.1017/S0033291709006060. Epub 2009 May 29. No abstract available.

PMID:
19476691
10.

Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia.

Molina V, Reig S, Sanz J, Palomo T, Benito C, Sánchez J, Sarramea F, Pascau J, Desco M.

Schizophr Res. 2005 Dec 1;80(1):61-71. Epub 2005 Sep 16.

PMID:
16150576
11.

Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia.

Boonstra G, van Haren NE, Schnack HG, Cahn W, Burger H, Boersma M, de Kroon B, Grobbee DE, Hulshoff Pol HE, Kahn RS.

J Clin Psychopharmacol. 2011 Apr;31(2):146-53. doi: 10.1097/JCP.0b013e31820e3f58.

PMID:
21346618
12.

A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics.

Kumari V, Antonova E, Geyer MA, Ffytche D, Williams SC, Sharma T.

Int J Neuropsychopharmacol. 2007 Aug;10(4):463-77. Epub 2006 Aug 21.

PMID:
16923324
13.

Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings.

Navari S, Dazzan P.

Psychol Med. 2009 Nov;39(11):1763-77. doi: 10.1017/S0033291709005315. Epub 2009 Apr 2. Review.

PMID:
19338710
14.

Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone.

Massana G, Salgado-Pineda P, Junqué C, Pérez M, Baeza I, Pons A, Massana J, Navarro V, Blanch J, Morer A, Mercader JM, Bernardo M.

J Clin Psychopharmacol. 2005 Apr;25(2):111-7.

PMID:
15738741
15.

Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

Fusar-Poli P, Smieskova R, Kempton MJ, Ho BC, Andreasen NC, Borgwardt S.

Neurosci Biobehav Rev. 2013 Sep;37(8):1680-91. doi: 10.1016/j.neubiorev.2013.06.001. Epub 2013 Jun 14.

16.

Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study.

Dazzan P, Morgan KD, Orr K, Hutchinson G, Chitnis X, Suckling J, Fearon P, McGuire PK, Mallett RM, Jones PB, Leff J, Murray RM.

Neuropsychopharmacology. 2005 Apr;30(4):765-74.

17.

Changes in cortical volume with olanzapine in chronic schizophrenia.

Molina V, Reig S, Sanz J, Palomo T, Benito C, Sánchez J, Pascau J, Desco M.

Pharmacopsychiatry. 2007 Jul;40(4):135-9.

PMID:
17694474
18.

Review of longitudinal functional neuroimaging studies of drug treatments in patients with schizophrenia.

Davis CE, Jeste DV, Eyler LT.

Schizophr Res. 2005 Oct 1;78(1):45-60. Review.

PMID:
15979287
19.

Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V.

Arch Gen Psychiatry. 2011 Feb;68(2):128-37. doi: 10.1001/archgenpsychiatry.2010.199.

20.

Neurologic comorbidities in schizophrenia.

Nasrallah HA.

J Clin Psychiatry. 2005;66 Suppl 6:34-46. Review.

PMID:
16107182
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk